Sino Biopharmaceutical Limited (SBHMY)

Sino Biopharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 26, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	19,833	7,500	8,173	10,832	13,133	18,176
Market Cap Growth	69.26%	-8.23%	-24.55%	-17.52%	-27.74%	3.57%
Enterprise Value	20,471	8,299	8,498	11,564	14,636	18,844
Last Close Price	20.05	8.21	9.12	11.07	13.57	16.82
PE Ratio	36.70	15.64	24.85	29.37	5.71	42.82
PS Ratio	4.65	1.90	2.21	2.87	3.11	5.02
PB Ratio	3.10	1.28	1.52	1.97	2.21	5.29
P/TBV Ratio	4.70	1.78	1.96	2.59	2.84	7.22
P/FCF Ratio	-	9.68	11.60	14.88	22.84	30.42
P/OCF Ratio	-	8.28	9.55	11.93	15.55	22.28
EV/Sales Ratio	4.76	2.10	2.30	3.07	3.46	5.20
EV/EBITDA Ratio	21.18	8.79	9.45	12.75	17.05	21.73
EV/EBIT Ratio	25.46	10.44	11.08	14.81	20.07	30.02
EV/FCF Ratio	-	10.71	12.06	15.88	25.46	31.54
Debt / Equity Ratio	0.26	0.23	0.33	0.37	0.33	0.63
Debt / EBITDA Ratio	1.73	1.39	1.97	2.22	2.21	2.48
Debt / FCF Ratio	-	1.72	2.54	2.81	3.36	3.64
Asset Turnover	0.43	0.45	0.41	0.42	0.50	0.56
Inventory Turnover	2.83	2.44	2.31	2.10	2.79	2.93
Quick Ratio	1.14	1.11	0.90	1.15	1.38	1.87
Current Ratio	1.36	1.26	1.05	1.29	1.53	2.08
Return on Equity (ROE)	15.40%	11.82%	12.12%	11.94%	55.25%	20.20%
Return on Assets (ROA)	5.07%	5.62%	5.33%	5.40%	5.37%	6.05%
Return on Capital (ROIC)	6.55%	7.02%	6.60%	6.60%	6.69%	7.79%
Return on Capital Employed (ROCE)	11.50%	12.70%	13.30%	12.30%	10.30%	11.30%
Earnings Yield	2.72%	6.39%	4.02%	3.40%	17.51%	2.33%
FCF Yield	-	10.33%	8.62%	6.72%	4.38%	3.29%
Dividend Yield	0.97%	0.11%	0.07%	0.14%	0.08%	0.06%
Payout Ratio	-	52.76%	27.13%	49.84%	6.42%	42.84%
Buyback Yield / Dilution	2.10%	1.26%	2.57%	1.38%	-2.57%	0.06%
Total Shareholder Return	3.06%	1.37%	2.64%	1.52%	-2.49%	0.11%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.